Abstract
The association between HCV infection and myocardial disorders remains unclear. This study aimed to assess whether or not HCV infection influences myocardial dysfunction by the use of NT-proBNP, a sensitive marker of myocardial dysfunction. A total of 198 participants [99 patients with chronic HCV infection (aged 46–68 years) and 99 anti-HCV-negative sex and age matched controls] were examined. Serum HCV-RNA level and HCV genotype were tested and liver biopsy was done only for the patient group. The NT-proBNP concentration of the HCV patients (mean 71.6 ± 79.1 pg/ml; median 46.0 pg/ml, range 5.0–400.0) was significantly higher than that of the controls (mean 39.8 ± 24.4 pg/ml; median 35.8 pg/ml, range 7.0–108.0) (P < 0.05). 20.0 % of the HCV patients and 0.6 % of the controls had high NT-proBNP (higher than 125 pg/ml; the single cut off point for patients under 75 years of age) (P < 0.05). Stepwise multiple regression analysis revealed that chronic HCV infection was independently correlated with NT-proBNP level after adjustment for parameters that might influence NT-proBNP (P = 0.005). Our data suggest that chronic HCV infection is associated with increased NT-proBNP, indicating that chronic HCV infection might induce myocardial dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
R.J. Johnson, D.R. Gretch, H. Yamabe et al., Membranoproliferative glomerulonephritis associated with hepatitis C virus infection in the United States, 1998 through 1994. N. Engl. J. Med. 341, 556–562 (1999)
H.B. El-Serag, H. Hampel, C. Yeh, L. Rabeneck, Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36, 1439–1445 (2002)
P. Cacoub, C. Renou, E. Rosenthal et al., Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltim.) 79, 47–56 (2000)
A. Matsumori, Y. Matoba, S. Sasayama, Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92, 2519–2525 (1995)
M. Okabe, K. Fukuda, K. Arakawa et al., Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96, 22–24 (1997)
G. Palladini, C. Campana, C. Klersy et al., Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107, 2440–2445 (2003)
T.J. Wang, M.G. Larson, D. Levy et al., Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N. Engl. J. Med. 350, 655–663 (2004)
A. Matsumori, T. Shimada, N.M. Chapman et al., Myocarditis and heart failure associated with hepatitis C virus infection. J. Card. Fail. 12, 293–298 (2006)
A. Antonelli, C. Ferri, S.M. Ferrari, S. Marchi et al., N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with hepatitis C. J. Interferon Cytokine Res. 30, 359–363 (2010)
A. Zaphiriou, S. Robb, T. Murray-Thomas et al., The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur. J. Heart Fail. 7, 537–541 (2005)
J.L. Januzzi Jr., C.A. Camargo, S. Anwaruddin et al., The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 95, 948–954 (2005)
The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol. Int. 1, 2–20 (2010)
J. Hayashi, Y. Kishihara, K. Yamaji et al., Hepatitis C viral quasi species and liver damage in patients with chronic hepatitis C virus infection. Hepatology 25, 697–701 (1997)
J. Hayashi, N. Furusyo, I. Ariyama et al., A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia. J. Infect. Dis. 181, 1523–1527 (2000)
N. Furusyo, M. Katoh, Y. Tanabe et al., Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group. World J. Gastroenterol. 12, 784–790 (2006)
K. Okada, N. Maeda, M. Tatsukawa et al., The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population. Atherosclerosis 173, 329–337 (2004)
M. Emoto, Y. Nishizawa, K. Maekawa et al., Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22, 818–822 (1999)
H. Mahrholdt, A. Wagner, C.C. Deluigi et al., Presentation, patterns of myocardial image, and clinical course of viral myocarditis. Circulation 114, 1581–1590 (2006)
A. Frustaci, C. Chimenti, F. Calabrese et al., Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107, 857–863 (2003)
K.L. Baughman, Diagnosis of myocarditis: death of Dallas criteria. Circulation 113, 593–595 (2006)
R.E. Eckart, S.S. Love, J.E. Atwood et al., Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J. Am. Coll. Cardiol. 44, 201–205 (2004)
T.A. McDonagh, A.D. Cunningham, C.E. Morrison et al., Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86, 21–26 (2001)
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okada, K., Furusyo, N., Ogawa, E. et al. Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptide. Endocrine 43, 200–205 (2013). https://doi.org/10.1007/s12020-012-9688-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9688-x